% Expired Patents = 100.0

CIPO Patents = 1

Forward Citations = 2

Loading Chart...

6 inventors (with patents filed for the assignee):

Clinton J Dahlberg (2 out of 12 patents)

Brian J Carroll (2 out of 6 patents)

Anuradha Desai (2 out of 5 patents)

4. Veera Konda (2 out of 13 patents)

5. Jan Urban (2 out of 5 patents)

6. Gary K Darland (2 out of 23 patents)

2 patents: Sort by Forward Citations

1. 8410179 - Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods (2013-04-02),

2. 8410178 - CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods (2013-04-02),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

2 Patents

#673 in Seattle, WA

#2,345 in Washington

#94,841 in US

Seattle, WA, United States of America

Kindex Therapeutics, LLC

Forward Citations = 2

6 inventors:

Clinton J Dahlberg (2 out of 12 patents)

Brian J Carroll (2 out of 6 patents)

Anuradha Desai (2 out of 5 patents)

4. Veera Konda (2 out of 13 patents)

5. Jan Urban (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kindex Therapeutics, LLC. Retrieved from https://idiyas.com/company/kindex-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]